The Department of Energy’s semiautonomous National Nuclear Security Administration has awarded $10 million in Phase II funding to SHINE Medical Technologies as part of the agency’s domestic supply program for molybdenum-99 (mo-99).
The funding is part…
Morning Briefing - December 14, 2016
Visit Archives | Return to Issue PDF
Visit Archives | Return to Issue PDF
Morning Briefing
Article 5 of 6
December 14, 2016
New Award Brings NNSA-SHINE Supply Agreement to $50M
Partner Content
Jobs